As the rare disease community strives to better understand AGU, consider these tools and partner sites for continued learning about life with this disease.

AGU Clinical Trials

There is a growing body of research on aspartylglucosaminuria and the various AGA gene variants that cause it. This research is intended to fuel advances for the AGU patient and healthcare community.

There are a limited number of trials related to aspartylglucosaminuria. All current clinical trials are listed on

Get to Know the AGU Community

Additional Resources

Medical articles published about Aspartylglucosaminuria (AGU) can be found below:

Aronson, N.N. (1999). Aspartylglycosaminuria: biochemistry and molecular biology. Biochimica Biophysica Acta, 1455(2-3):139-54. Retrieved June 5, 2019 from link.

Saarela J., Oinonen, C., Jalanko, A., Rouvinen, J., Peltonen, L. (2004). Autoproteolytic activation of human aspartylglucosaminidase. The Biochemical Journal, 378(Pt 2):363-71. Retrieved June 5, 2019 from link.